Ondansetron HCL 4 MG tablet 500S
Ended Awarded Last action
- Contract number
- SPE2DR26F9LS0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,013
Award facts
- Contract value 100% obligated
- $15,013.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,013.42 to AmerisourceBergen Drug Corp for the supply of 500 tablets of Ondansetron HCl 4 mg. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of January 20, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Ondansetron is a commonly used antiemetic medication in military and federal healthcare settings, and this order represents a routine pharmaceutical replenishment under the company's existing contract vehicle with the Defense Logistics Agency.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 single-award contract valued through December 2026 that serves as the primary vehicle for delivering comprehensive pharmaceutical and medical supply support to military healthcare programs globally. AmerisourceBergen Drug Corp operates as a subsidiary of its parent company, Cencora, Inc. (doing business as AmerisourceBergen), which holds the overarching IDC with the Defense Logistics Agency. The contract received no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete successfully in open federal pharmaceutical procurement for the Department of Defense medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9LS0?
SPE2DR26F9LS0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F9LS0 worth?
The government has obligated $15,013 on SPE2DR26F9LS0.
Is contract SPE2DR26F9LS0 an order under another contract?
Yes. SPE2DR26F9LS0 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LS0 competed?
The extent of competition for SPE2DR26F9LS0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award